Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.9.2025Laboratories THEA (LTH)76499Spersadex comp. (int opo 1x5 ml (fľ.LDPE))26.6.2025Z
 16.9.2025Egis Pharmaceuticals PLC (EGI)2806DTalliton 12,5 mg (tbl 30x12,5 mg (blis.OPA/Al/PVC/Al))19.9.2025Z
 16.9.2025Egis Pharmaceuticals PLC (EGI)2538CEgilok 50 mg (tbl 100x50 mg (liek.skl.hnedá))8.10.2025Z
 16.9.2025Accord Healthcare Polska Sp. z o.o. (AOK)0796BEtopozid Accord 20 mg/ml koncentrát na infúzny roztok (con inf 1x5 ml/100 mg (liek.inj.skl.))16.9.2025Z
 16.9.2025Accord Healthcare Polska Sp. z o.o. (AOK)30416Quetiapine Accord 300 mg filmom obalené tablety s predĺženým uvoľňovaním (tbl plg 60x300 mg (blis.PVC/PVDC/Al))16.9.2025Z
 16.9.2025Accord Healthcare Polska Sp. z o.o. (AOK)30411Quetiapine Accord 200 mg filmom obalené tablety s predĺženým uvoľňovaním (tbl plg 60x200 mg (blis.PVC/PVDC/Al))16.9.2025Z
 16.9.2025Accord Healthcare S.L.U (ACC-ES)8468EIMULDOSA 90 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x1 ml/90 mg (striek.inj.skl.napl.))6.5.2025U
 16.9.2025Accord Healthcare S.L.U (ACC-ES)8467EIMULDOSA 45 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,5 ml/45 mg (striek.inj.skl.napl.))6.5.2025U
 16.9.2025Accord Healthcare S.L.U (ACC-ES)8469EIMULDOSA 130 mg koncentrát na infúzny roztok (con inf 1x26 ml/130 mg (liek.inj.skl.))6.5.2025U
 16.9.2025Novo Nordisk A/S (NOO)41374NovoMix 30 FlexPen (sus inj 10x3 ml/300 U (náplň skl. v napl.viacd.jedn.pere))12.9.2025R
 16.9.2025GlaxoSmithKline Biologicals S.A. (GAG)45368Boostrix (sus iru 1x0,5 ml (striek.skl.napl. s ihlami/bez ihiel))15.9.2025O
 15.9.2025TILLOMED PHARMA GmbH (TLT-2)2375EFoscarnet Tillomed 24 mg/ml infúzny roztok (sol inf 1x250 ml/6 000 mg (fľ.skl.))18.9.2025O
 12.9.2025Mylan Pharmaceuticals Limited (MLB-IE-1)5222AMemantin Mylan 10 mg filmom obalené tablety (tbl flm 56x10 mg (blis.PVC/PVDC/Al))16.9.2025R
 12.9.2025McNeil Healthcare (Ireland) Limited (MCP-3)1279EImodium (cps dur 12x2 mg (blis.PVC/Al))15.9.2025R
 12.9.2025Viatris Healthcare Limited (VIM-1)86087Thioctacid 600 HR (tbl flm 100x600 mg (liek.skl.hnedá))22.9.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)